Pioglitazone Protects Diabetes Mellitus (DM) Patients Against Re-Infarction (PPAR Study)

NCT00212004 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

630

Enrollment

OTHER

Sponsor class

Stopped Limited budget to continue this study

Conditions

Diabetes Mellitus
Myocardial Infarction

Interventions

DRUG: pioglitazone
OTHER: control

Sponsor

National Cerebral and Cardiovascular Center, Japan

Collaborators

[object Object]